AmirPayvand Research and Development Company After the pandemic of CoVID-19 disease (spread of various species of coronavirus) in the world and Iran in order to increase the quality of laboratory diagnostic services in the diagnostic screening of coronavirus variants designed and manufactured a molecular screening kit for SARS virus CoV-2 caused the disease of Covid-19 and VOC B.1.1.7 in the research and development department under the responsibility and management of Dr. Behzad Poopak in order to localize the production of the mentioned kit.
From the middle of 1399 and with the expansion of different variants of the SARS-CoV-2 virus, the necessary scientific and technical researches were carried out regarding the identification of the B.1.17 (Alpha) variant, and according to the technical trade and skill of producing two other molecular diagnostic kits of Classic SARS CoV-2 and Covid-19 screening, influenza type A & B were present in this company, the production of new kits proceeded with higher speed and accuracy. On 1/3/1400, during the evaluation letter, the analysis of the kit was done as the final product of AmirPayvand Company, and considering the follow-ups, the final product license was obtained from the General Directorate of Medical Equipment on 12/3/1400 in the letter No. 604/664.
Click here for more information about the product.
